|
Volumn 118, Issue 6, 1995, Pages 967-972
|
Clinical islet transplantation experience of the University of California Islet Transplant Consortium
a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
HYDROCORTISONE;
METHYLPREDNISOLONE;
OKT 3;
PREDNISOLONE;
CLINICAL ARTICLE;
CONFERENCE PAPER;
FEMALE;
GRAFT PRESERVATION;
HEALTH CARE FACILITY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
LABORATORY;
MALE;
ORGAN DONOR;
PANCREAS ISLET TRANSPLANTATION;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
ADULT;
BLOOD GLUCOSE;
C-PEPTIDE;
CALIFORNIA;
CHILD;
DIABETES MELLITUS;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
INSULIN;
ISLETS OF LANGERHANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
MALE;
MIDDLE AGE;
REGISTRIES;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TISSUE DONORS;
|
EID: 0028850671
PISSN: 00396060
EISSN: None
Source Type: Journal
DOI: 10.1016/S0039-6060(05)80101-1 Document Type: Article |
Times cited : (24)
|
References (11)
|